Teva Pharma (TEVA) PT Raised to $16 at Mizuho Securities on Announced Major Cost Cuts
Tweet Send to a Friend
Mizuho Securities raised its price target on Teva Pharma (NYSE: TEVA) to $16.00 (from $12.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
